RecruitingNCT04758325

The Sarcoma Biology and Outcome Project

A Prospective Registry Study on Biological Disease Profile, Intervention Type and Clinical Outcome in Adolescent and Adult Patients With Soft-tissue and Bone Sarcoma


Sponsor

Prof. Dr. Richard F Schlenk

Enrollment

3,000 participants

Start Date

Jul 23, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

SarcBOP - An interdisciplinary and translational registry SarcBOP aims to establish a database that integrates every aspect possibly relevant to sarcoma treatment and research. SarcBOP thus will not be limited to specific questions or patient groups, but instead will build a comprehensive database including clinical, pathologic, and radiologic information, multi-layered molecular data, and patient-reported outcomes, combined with a dedicated biobank for tissue samples and liquid biopsies. As the study integrates seamlessly with the clinical activities of the Heidelberg Sarcoma Center, the Molecular Diagnostics Program of NCT Heidelberg, including the NCT/DKTK MASTER Program, and with the NCT Trial Center, including the PMO Clinical Trials Program, SarcBOP will generate a comprehensive and continuously growing resource for clinicians, researchers, and, finally, patients.


Eligibility

Min Age: 12 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study collecting biological samples and clinical information from patients with soft tissue or bone sarcomas to better understand how these cancers behave and respond to treatment over time. **You may be eligible if...** - You are 12 years or older - You have a suspected or confirmed diagnosis of a soft tissue or bone sarcoma - You are able to understand what the registry involves and give written consent **You may NOT be eligible if...** - You have a severe neurological or psychiatric disorder that prevents you from giving informed consent - You are under 12 years old Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Center for Tumour Diseases, University Hospital Heidelberg

Heidelberg, Baden-Wurttemberg, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04758325


Related Trials